https://www.ispor.org/vih-articles/Volume-12--Issue-3/PMS18-ESTIMATION-OF-COSTS-RELATED-TO-ADVERSE-EVENTS-IN-NSAID-TREATMENT-OF-OSTEOARTHRITIS---A-COMPARISON-BETWEEN-CELECOXIB-AND-IBUPROFEN-USING-A-VALIDATED-MODEL
PMS18 ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS - A...